Cohen PR, Beltrani VP, Grossman ME, Disseminated herpes zoster in patients with human immunodeficiency virus infection, JAMA 1988; 84: 1076-80.
Nelson JA, Ghazal P, Wiley CA, Role of opportunistic viral infections in AIDS, AIDS 1990; 4: 1-10.
Snoeck R, Schols O, Sadzot-Delvaux C, Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation ofanti-VZV agents, J Virol Methods 1992; 38: 243-54.
Linnemann CC Jr, Biron KK, Hoppenjans WG, Solinger AM, Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy, AIDS 1990; 4: 577-9.
Jacobson MA, Berger TG, Fikrig S, Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS), Ann Intern Med 1990; 112: 187-91.
Safrin S, Berger TG, Gilson I, Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection, Ann Intern Med 1991; 115: 19-21.
Talarico CL, Phelps WE, Biron KK, Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS, J Virol 1993; 67: 1024-33.
Snoeck R, De Clercq E, (S)-I-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC), A potent and selective inhibitor of cytomegalovirus infection in vitro and in vivo, In: Touraine JL, Traeger J, Betvel H, Dubernard JM, Revillard JP, Dupuy C, eds, Transplantation and clinical immunology XXIII, Amsterdam: Elsevier Science Publishers, 1991: 169-76.
